@article{c0a548a32e034b96a5863a0c469f9b1a,
title = "Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma",
keywords = "Hodgkin lymphoma, autologous stem cell transplantation, bendamustine, brentuximab vedotin, first salvage therapy",
author = "LaCasce, {Ann S.} and Bociek, {R. Gregory} and Ahmed Sawas and Paolo Caimi and Edward Agura and Jeffrey Matous and Ansell, {Stephen M.} and Crosswell, {Howland E.} and Miguel Islas-Ohlmayer and Caroline Behler and Eric Cheung and Andres Forero-Torres and Julie Vose and O{\textquoteright}Connor, {Owen A.} and Neil Josephson and Yinghui Wang and Ranjana Advani",
note = "Funding Information: The authors thank the patients and clinical study teams who participated in this research. Medical writing and editorial support were provided by Laurie LaRusso, Chestnut Medical Communications, and Eric Bertelsen, Seattle Genetics, Inc., and paid for by Seattle Genetics. This work was supported by research funding from Seattle Genetics, Inc. Funding Information: The authors thank the patients and clinical study teams who participated in this research. Medical writing and editorial support were provided by Laurie LaRusso, Chestnut Medical Communications, and Eric Bertelsen, Seattle Genetics, Inc., and paid for by Seattle Genetics. This work was supported by research funding from Seattle Genetics, Inc.",
year = "2020",
month = may,
day = "1",
doi = "10.1111/bjh.16499",
language = "English (US)",
volume = "189",
pages = "e86--e90",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",
}